BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1294523)

  • 1. The influence of anaerobiosis on the activity of fosfomycin trometamol.
    Greenwood D; Brown J; Edwards R
    Infection; 1992; 20 Suppl 4():S305-9. PubMed ID: 1294523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditions.
    Inouye S; Watanabe T; Tsuruoka T; Kitasato I
    J Antimicrob Chemother; 1989 Nov; 24(5):657-66. PubMed ID: 2599990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the activity of the trometamol salt of fosfomycin.
    Greenwood D; Jones A; Eley A
    Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on the bactericidal activity of fosfomycin using the membrane filter-agar dilution method and the time-kill technique.
    Haag R; Hoffmann R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):260-72. PubMed ID: 3909700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium compositions and culture conditions for the assay of fosfomycin susceptibility by Etest.
    Horii T; Kimura T; Odagiri T; Shibayama K; Ohta M
    J Infect Chemother; 2000 Mar; 6(1):30-4. PubMed ID: 11810528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of sensitivity to fosfomycin in bacteria isolated in 1973, 1974 and 1975 in the Servicio de Microbiologia y Epidemiologia of the 'Clinica Puerta de Hierro', Madrid.
    Dámaso D; Moreno-López M; Martínez-Beltrán J
    Chemotherapy; 1977; Suppl 1():104-11. PubMed ID: 832509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of culture media on the fosfomycin sensitivity of six Serratia strains and their resistant mutants.
    Drugeon HB; Courtieu AL
    Chemotherapy; 1982; 28(5):345-50. PubMed ID: 7140421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the disc sensitivity test for fosfomycin (author's transl)].
    Kanazawa Y; Kuramata T; Matsumoto K
    Jpn J Antibiot; 1982 Mar; 35(3):794-800. PubMed ID: 7097982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines.
    Greenwood D; Edwards R; Brown J; Ridout P
    Infection; 1992; 20 Suppl 4():S302-4. PubMed ID: 1294522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity of clinical bacterial strains to dioxidine in vitro under aerobic and anaerobic conditions].
    Ponomareva TR
    Antibiot Med Biotekhnol; 1987 Mar; 32(3):199-202. PubMed ID: 3579247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
    García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
    J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fosfomycin against 'problem' gram-positive cocci.
    Hamilton-Miller JM
    Microbios; 1992; 71(287):95-103. PubMed ID: 1453987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trometamol salt of fosfomycin: microbiological evaluation.
    Greenwood D; Coyle S; Andrew J
    Eur Urol; 1987; 13 Suppl 1():69-75. PubMed ID: 3552702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between bactericidal activity of fosfomycin trometamol in an in vitro model of the urinary bladder and susceptibility testing.
    Pinasi C; Albini E; Marca G
    Eur Urol; 1987; 13 Suppl 1():80-5. PubMed ID: 3569383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility testing procedures for fosfomycin tromethamine.
    Barry AL; Fuchs PC
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1235-8. PubMed ID: 1929270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G; McKevitt M; Elborn JS; Tunney MM
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
    Dette GA; Knothe H; Schönenbach B; Plage G
    J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of inoculum and mutant frequency on fosfomycin MIC discrepancies by agar dilution and broth microdilution methods in Enterobacteriaceae.
    Ballestero-Téllez M; Docobo-Pérez F; Rodríguez-Martínez JM; Conejo MC; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2017 May; 23(5):325-331. PubMed ID: 28062317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial activity of fosfomycin under various conditions against standard strains, beta-lactam resistant strains, and multidrug efflux system mutants].
    Mikuniya T; Hiraishi T; Maebashi K; Ida T; Takata T; Hikida M; Yamada S; Gotoh N; Nishino T
    Jpn J Antibiot; 2005 Apr; 58(2):105-22. PubMed ID: 15997654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
    Gismondo MR; Romeo MA; Lo Bue AM; Chisari G; Nicoletti G
    Chemioterapia; 1986 Aug; 5(4):278-82. PubMed ID: 3094965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.